Back
Jazz Pharmaceuticals PLC 10K Form
Sell
41
JAZZ
Jazz Pharmaceuticals PLC
Last Price:
$111.01
Seasonality Move:
48.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-02 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2023-11-08 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2023-08-09 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2023-05-10 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2022-11-09 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
| 2022-08-03 | 10Q | JAZZ/Jazz Pharmaceuticals PLC Quarterly |
Receive JAZZ News And Ratings
See the #1 stock for the next 7 days that we like better than JAZZ
JAZZ Financial Statistics
Sales & Book Value
| Annual Sales: | $4.1B |
|---|---|
| Cash Flow: | $390.9M |
| Price / Cash Flow: | 4.71 |
| Annual Sales: | $67.75 |
| Price / Book: | 1.62 |
Profitability
| EPS (TTM): | 7.50000 |
|---|---|
| Net Income (TTM): | $482.2M |
| Gross Margin: | $3.6B |
| Return on Equity: | 12.12% |
| Return on Assets: | 4.12% |
Jazz Pharmaceuticals PLC Earnings Forecast
Key Jazz Pharmaceuticals PLC Financial Ratios
-
The Gross Profit Margin over the past 20 years for JAZZ is 89.05%.
-
The Selling, General & Administrative Expenses for JAZZ have been equal to 34.05% of Gross Profit Margin.
-
The Research & Development expenses have been 21.73% of Revenue.
-
The Interest Expense is 42.51% of Operating Income.
-
The Net Earning history of JAZZ is 13.77% of Total Revenues.
-
Per Share Earnings over the last 21 years have been positive in 13 years.
Jazz Pharmaceuticals PLC Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | JAZZ |
| CUSIP: | G50871 |
| Website: | jazzpharmaceuticals.com |
Debt
| Debt-to-Equity Ratio: | 1.29 |
|---|---|
| Current Ratio: | 3.38 |
| Quick Ratio: | 2.64 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.69 |
|---|---|
| Forward P/E Ratio: | 5.1 |
JAZZ Technical Analysis vs Fundamental Analysis
Sell
41
Jazz Pharmaceuticals PLC (JAZZ)
is a Sell
Is Jazz Pharmaceuticals PLC a Buy or a Sell?
-
Jazz Pharmaceuticals PLC stock is rated a SellThe current Jazz Pharmaceuticals PLC [JAZZ] share price is $109.78. The Score for JAZZ is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.